205 related articles for article (PubMed ID: 36246263)
1. Integrative analysis of the mouse fecal microbiome and metabolome reveal dynamic phenotypes in the development of colorectal cancer.
Liu J; Qi M; Qiu C; Wang F; Xie S; Zhao J; Wu J; Song X
Front Microbiol; 2022; 13():1021325. PubMed ID: 36246263
[TBL] [Abstract][Full Text] [Related]
2. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
[No Abstract] [Full Text] [Related]
3. Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis.
Kim M; Vogtmann E; Ahlquist DA; Devens ME; Kisiel JB; Taylor WR; White BA; Hale VL; Sung J; Chia N; Sinha R; Chen J
mBio; 2020 Feb; 11(1):. PubMed ID: 32071266
[TBL] [Abstract][Full Text] [Related]
4. Alterations of the Gut Microbiome and Fecal Metabolome in Colorectal Cancer: Implication of Intestinal Metabolism for Tumorigenesis.
Du X; Li Q; Tang Z; Yan L; Zhang L; Zheng Q; Zeng X; Chen G; Yue H; Li J; Zhao M; Han YP; Fu X
Front Physiol; 2022; 13():854545. PubMed ID: 35600308
[No Abstract] [Full Text] [Related]
5. Altered gut metabolites and microbiota interactions are implicated in colorectal carcinogenesis and can be non-invasive diagnostic biomarkers.
Coker OO; Liu C; Wu WKK; Wong SH; Jia W; Sung JJY; Yu J
Microbiome; 2022 Feb; 10(1):35. PubMed ID: 35189961
[TBL] [Abstract][Full Text] [Related]
6. Meta-Analysis of Altered Gut Microbiota Reveals Microbial and Metabolic Biomarkers for Colorectal Cancer.
Avuthu N; Guda C
Microbiol Spectr; 2022 Aug; 10(4):e0001322. PubMed ID: 35766483
[TBL] [Abstract][Full Text] [Related]
7. Fecal Microbiota and Gut Microbe-Derived Extracellular Vesicles in Colorectal Cancer.
Park J; Kim NE; Yoon H; Shin CM; Kim N; Lee DH; Park JY; Choi CH; Kim JG; Kim YK; Shin TS; Yang J; Park YS
Front Oncol; 2021; 11():650026. PubMed ID: 34595105
[TBL] [Abstract][Full Text] [Related]
8. Untangling determinants of gut microbiota and tumor immunologic status through a multi-omics approach in colorectal cancer.
Zhang SL; Cheng LS; Zhang ZY; Sun HT; Li JJ
Pharmacol Res; 2023 Feb; 188():106633. PubMed ID: 36574857
[TBL] [Abstract][Full Text] [Related]
9. Surgical Treatment for Colorectal Cancer Partially Restores Gut Microbiome and Metabolome Traits.
Shiroma H; Shiba S; Erawijantari PP; Takamaru H; Yamada M; Sakamoto T; Kanemitsu Y; Mizutani S; Soga T; Saito Y; Shibata T; Fukuda S; Yachida S; Yamada T
mSystems; 2022 Apr; 7(2):e0001822. PubMed ID: 35311577
[TBL] [Abstract][Full Text] [Related]
10. Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations.
Sinha R; Ahn J; Sampson JN; Shi J; Yu G; Xiong X; Hayes RB; Goedert JJ
PLoS One; 2016; 11(3):e0152126. PubMed ID: 27015276
[TBL] [Abstract][Full Text] [Related]
11. Microbiome-metabolomic analysis of the impact of Zizyphus jujuba cv. Muzao polysaccharides consumption on colorectal cancer mice fecal microbiota and metabolites.
Ji X; Hou C; Zhang X; Han L; Yin S; Peng Q; Wang M
Int J Biol Macromol; 2019 Jun; 131():1067-1076. PubMed ID: 30926487
[TBL] [Abstract][Full Text] [Related]
12. Integrated metagenomic and metabolomic analysis reveals distinct gut-microbiome-derived phenotypes in early-onset colorectal cancer.
Kong C; Liang L; Liu G; Du L; Yang Y; Liu J; Shi D; Li X; Ma Y
Gut; 2023 Jun; 72(6):1129-1142. PubMed ID: 35953094
[TBL] [Abstract][Full Text] [Related]
13. Progress of gut microbiome and its metabolomics in early screening of colorectal cancer.
Zhou L; Jiang Z; Zhang Z; Xing J; Wang D; Tang D
Clin Transl Oncol; 2023 Jul; 25(7):1949-1962. PubMed ID: 36790675
[TBL] [Abstract][Full Text] [Related]
14. Integrated analysis of the faecal metagenome and serum metabolome reveals the role of gut microbiome-associated metabolites in the detection of colorectal cancer and adenoma.
Chen F; Dai X; Zhou CC; Li KX; Zhang YJ; Lou XY; Zhu YM; Sun YL; Peng BX; Cui W
Gut; 2022 Jul; 71(7):1315-1325. PubMed ID: 34462336
[TBL] [Abstract][Full Text] [Related]
15. Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer.
Qu R; Zhang Y; Ma Y; Zhou X; Sun L; Jiang C; Zhang Z; Fu W
Adv Sci (Weinh); 2023 Aug; 10(23):e2205563. PubMed ID: 37263983
[TBL] [Abstract][Full Text] [Related]
16. From adenoma to CRC stages: the oral-gut microbiome axis as a source of potential microbial and metabolic biomarkers of malignancy.
Russo E; Gloria LD; Nannini G; Meoni G; Niccolai E; Ringressi MN; Baldi S; Fani R; Tenori L; Taddei A; Ramazzotti M; Amedei A
Neoplasia; 2023 Jun; 40():100901. PubMed ID: 37058886
[TBL] [Abstract][Full Text] [Related]
17. Microbiome and metabolic features of tissues and feces reveal diagnostic biomarkers for colorectal cancer.
Feng J; Gong Z; Sun Z; Li J; Xu N; Thorne RF; Zhang XD; Liu X; Liu G
Front Microbiol; 2023; 14():1034325. PubMed ID: 36712187
[TBL] [Abstract][Full Text] [Related]
18. The Colorectal Cancer Microbiota Alter Their Transcriptome To Adapt to the Acidity, Reactive Oxygen Species, and Metabolite Availability of Gut Microenvironments.
Lamaudière MTF; Arasaradnam R; Weedall GD; Morozov IY
mSphere; 2023 Apr; 8(2):e0062722. PubMed ID: 36847536
[TBL] [Abstract][Full Text] [Related]
19. Microbial and metabolic profiles unveil mutualistic microbe-microbe interaction in obesity-related colorectal cancer.
Li J; Chen Z; Wang Q; Du L; Yang Y; Guo F; Li X; Chao Y; Ma Y
Cell Rep Med; 2024 Mar; 5(3):101429. PubMed ID: 38378003
[TBL] [Abstract][Full Text] [Related]
20. Interaction between Host MicroRNAs and the Gut Microbiota in Colorectal Cancer.
Yuan C; Burns MB; Subramanian S; Blekhman R
mSystems; 2018; 3(3):. PubMed ID: 29795787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
